Clearmind Medicine Inc.
Clearmind Medicine Inc. (CMND) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmnd · pe ratio · data through Oct 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Clearmind Medicine Inc. (CMND) measures how much investors pay for each dollar of the company's trailing earnings. CMND's current PE ratio of N/A is calculated by dividing its stock price of $3.83 by its TTM earnings per share of -$5.71.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-10-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Clearmind Medicine Inc.You CMND | $4M | N/A | — | -$5.71 |
 Can-Fite BioPharma Ltd. CANF | $2M | N/A | — | -$12.02 |
 Calidi Biotherapeutics, Inc. CLDI | $1M | N/A | — | -$4.63 |
 CNS Pharmaceuticals, Inc. CNSP | $3M | N/A | — | -$35.75 |
 GRI Bio, Inc. GRI | $0M | N/A | — | -$121.80 |
 Jaguar Health, Inc. JAGX | $0M | N/A | — | -$803.95 |
 Kazia Therapeutics Limited KZIA | $19M | N/A | — | -$18.90 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-10-31Latest FY2025 | — | $-3.03 | — | |
2024-10-31 FY2024 | — | $-6.78 | — | |
2023-10-31 FY2023 | — | $-170.07 | — | |
2022-10-31 FY2022 | — | $-916.76 | — | |
2021-10-31 FY2021 | — | $-473.14 | — | |
2020-10-31 FY2020 | — | $-50.78 | — | |
2019-10-31 FY2019 | — | $-33.78 | — | |
2018-10-31 FY2018 | — | $-73.53 | — | |
2017-10-31 FY2017 | — | $-2.14 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Clearmind Medicine Inc. (CMND) measures how much investors pay for each dollar of the company's trailing earnings. CMND's current PE ratio of N/A is calculated by dividing its stock price of $3.83 by its TTM earnings per share of -$5.71.
Frequently asked questions
CMND pe ratio · 6 questionsCMND's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.83 and TTM EPS of -$5.71. Data sourced from Financial Modeling Prep via CMND's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Clearmind Medicine Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08